We are analyzing https://link.springer.com/article/10.1007/s00432-006-0117-5.

Title:
The membrane-cytoskeleton organizer ezrin is necessary for hepatocellular carcinoma cell growth and invasiveness | Journal of Cancer Research and Clinical Oncology
Description:
The change of cell mobility is one of the preconditions of tumor metastasis. Cell skeleton alteration and rearrangement of F-actin was closely related to cell mobility. Ezrin is a membrane-cytoskeleton organizer that can mediate the rearrangement and the function of F-actin. In this paper, we investigated the effect of ezrin on hepatocellullar carcinoma cell growth and invasiveness. Hepatocellular carcinoma cell lines such as MHCC-1, MHCC97-H, SF7721, SMMC7721, Hep3B, and HepG2 were chosen in this study. We first examined the expression and the distribution of ezrin and F-actin in these cell lines using immunofluorescence, RT–PCR, and the western blot. Next we used small interfering RNA (siRNA) to down-regulate ezrin expression in MHCC-1, MHCC97-H, SF7721, and HepG2 to investigate the role of ezrin in tumor cell growth and invasiveness. Our preliminary results showed that the expression of ezrin and γ-actin in MHCC-1, MHCC97-H, and SF7721 with higher metastatic potential were obviously up-regulated than those in SMMC7721, Hep3B, and HepG2 with lower potential. No different expression of β-actin was found in the above tumor cell lines. The outcome of RNAi indicated that decreasing ezrin expression can notably inhibit the proliferation of the four hepatocellular carcinoma cell lines (p < 0.01, n = 10). The proportion of cells in G2-M phase also decreased after RNAi. The number of pseudopods decreased as well after RNAi treatment (p < 0.01, n = 5). The mobility and invasiveness of cancer cells decreased with decreasing ezrin expression tested by transwell assay (p < 0.01, n = 8). Ezrin plays an important role in the process of hepatocellular carcinoma cell proliferation, migration, and invasiveness.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Telecommunications
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

cell, ezrin, article, google, scholar, pubmed, cas, carcinoma, hepatocellular, expression, cancer, biol, growth, proteins, invasiveness, access, privacy, cookies, content, journal, research, tsukita, function, publish, search, membranecytoskeleton, organizer, liu, lines, small, role, rnai, cells, open, sci, erm, chen, protein, shanghai, essential, data, information, log, zhang, zhou, kangda, mobility, tumor, metastasis, factin,

Topics {✒️}

sf/hcf-c-met autocrine month download article/chapter kang-da liu c-terminal domain interactions membrane-cytoskeletal linking protein epidermal growth factor small interfering rna prostate cancer–endothelium interaction e-cadherin/beta-catenin hepatocellular carcinoma based rock-mediated fibroblast transformation membrane-cytoskeleton linker ezrin membrane-cytoskeleton organizer ezrin ezrin/radixin/moesin proteins ezrin regulates cell–cell hepatocellular carcinoma full article pdf tumor cell growth higher metastatic potential membrane-cytoskeleton organizer privacy choices/manage cookies cytoskeletal organizer ezrin wei-zhong wu related subjects endometrial cancer cells tumor cell lines cell skeleton alteration cell–matrix adhesion scaffolding proteins ebp50 check access instant access kang zhou immortalized mouse fibroblast binding membrane proteins cancer cells decreased article zhang ezrin/radixin/moesin european economic area clinical oncology aims zhi-jun wang mrna sequencing independent activation mechanisms key metastasic regulators conditions privacy policy activated erm proteins mei-yu hu article journal cancer research paracrine promote metastasis accepting optional cookies

Schema {🗺️}

WebPage:
      mainEntity:
         headline:The membrane-cytoskeleton organizer ezrin is necessary for hepatocellular carcinoma cell growth and invasiveness
         description:The change of cell mobility is one of the preconditions of tumor metastasis. Cell skeleton alteration and rearrangement of F-actin was closely related to cell mobility. Ezrin is a membrane-cytoskeleton organizer that can mediate the rearrangement and the function of F-actin. In this paper, we investigated the effect of ezrin on hepatocellullar carcinoma cell growth and invasiveness. Hepatocellular carcinoma cell lines such as MHCC-1, MHCC97-H, SF7721, SMMC7721, Hep3B, and HepG2 were chosen in this study. We first examined the expression and the distribution of ezrin and F-actin in these cell lines using immunofluorescence, RT–PCR, and the western blot. Next we used small interfering RNA (siRNA) to down-regulate ezrin expression in MHCC-1, MHCC97-H, SF7721, and HepG2 to investigate the role of ezrin in tumor cell growth and invasiveness. Our preliminary results showed that the expression of ezrin and γ-actin in MHCC-1, MHCC97-H, and SF7721 with higher metastatic potential were obviously up-regulated than those in SMMC7721, Hep3B, and HepG2 with lower potential. No different expression of β-actin was found in the above tumor cell lines. The outcome of RNAi indicated that decreasing ezrin expression can notably inhibit the proliferation of the four hepatocellular carcinoma cell lines (p < 0.01, n = 10). The proportion of cells in G2-M phase also decreased after RNAi. The number of pseudopods decreased as well after RNAi treatment (p < 0.01, n = 5). The mobility and invasiveness of cancer cells decreased with decreasing ezrin expression tested by transwell assay (p < 0.01, n = 8). Ezrin plays an important role in the process of hepatocellular carcinoma cell proliferation, migration, and invasiveness.
         datePublished:2006-06-20T00:00:00Z
         dateModified:2006-06-20T00:00:00Z
         pageStart:685
         pageEnd:697
         sameAs:https://doi.org/10.1007/s00432-006-0117-5
         keywords:
            Hepatocellular carcinoma
            Ezrin
            RNAi
            Invasiveness
            Oncology
            Cancer Research
            Internal Medicine
            Hematology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-006-0117-5/MediaObjects/432_2006_117_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-006-0117-5/MediaObjects/432_2006_117_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-006-0117-5/MediaObjects/432_2006_117_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-006-0117-5/MediaObjects/432_2006_117_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-006-0117-5/MediaObjects/432_2006_117_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-006-0117-5/MediaObjects/432_2006_117_Fig6_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-006-0117-5/MediaObjects/432_2006_117_Fig7_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-006-0117-5/MediaObjects/432_2006_117_Fig8_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-006-0117-5/MediaObjects/432_2006_117_Fig9_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-006-0117-5/MediaObjects/432_2006_117_Fig10_HTML.gif
         isPartOf:
            name:Journal of Cancer Research and Clinical Oncology
            issn:
               1432-1335
               0171-5216
            volumeNumber:132
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Yan Zhang
               affiliation:
                     name:Fudan University
                     address:
                        name:Experimental Center of Zhongshan Hospital, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mei-Yu Hu
               affiliation:
                     name:Fudan University
                     address:
                        name:Experimental Center of Zhongshan Hospital, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Wei-Zhong Wu
               affiliation:
                     name:Fudan University
                     address:
                        name:Liver Cancer Institute, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zhi-Jun Wang
               affiliation:
                     name:Fudan University
                     address:
                        name:Experimental Center of Zhongshan Hospital, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kang Zhou
               affiliation:
                     name:Fudan University
                     address:
                        name:Experimental Center of Zhongshan Hospital, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xi-Liang Zha
               affiliation:
                     name:Fudan University
                     address:
                        name:Department of Biochemistry and Molecular Biology, Shanghai Medical College, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kang-Da Liu
               affiliation:
                     name:Fudan University
                     address:
                        name:Experimental Center of Zhongshan Hospital, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The membrane-cytoskeleton organizer ezrin is necessary for hepatocellular carcinoma cell growth and invasiveness
      description:The change of cell mobility is one of the preconditions of tumor metastasis. Cell skeleton alteration and rearrangement of F-actin was closely related to cell mobility. Ezrin is a membrane-cytoskeleton organizer that can mediate the rearrangement and the function of F-actin. In this paper, we investigated the effect of ezrin on hepatocellullar carcinoma cell growth and invasiveness. Hepatocellular carcinoma cell lines such as MHCC-1, MHCC97-H, SF7721, SMMC7721, Hep3B, and HepG2 were chosen in this study. We first examined the expression and the distribution of ezrin and F-actin in these cell lines using immunofluorescence, RT–PCR, and the western blot. Next we used small interfering RNA (siRNA) to down-regulate ezrin expression in MHCC-1, MHCC97-H, SF7721, and HepG2 to investigate the role of ezrin in tumor cell growth and invasiveness. Our preliminary results showed that the expression of ezrin and γ-actin in MHCC-1, MHCC97-H, and SF7721 with higher metastatic potential were obviously up-regulated than those in SMMC7721, Hep3B, and HepG2 with lower potential. No different expression of β-actin was found in the above tumor cell lines. The outcome of RNAi indicated that decreasing ezrin expression can notably inhibit the proliferation of the four hepatocellular carcinoma cell lines (p < 0.01, n = 10). The proportion of cells in G2-M phase also decreased after RNAi. The number of pseudopods decreased as well after RNAi treatment (p < 0.01, n = 5). The mobility and invasiveness of cancer cells decreased with decreasing ezrin expression tested by transwell assay (p < 0.01, n = 8). Ezrin plays an important role in the process of hepatocellular carcinoma cell proliferation, migration, and invasiveness.
      datePublished:2006-06-20T00:00:00Z
      dateModified:2006-06-20T00:00:00Z
      pageStart:685
      pageEnd:697
      sameAs:https://doi.org/10.1007/s00432-006-0117-5
      keywords:
         Hepatocellular carcinoma
         Ezrin
         RNAi
         Invasiveness
         Oncology
         Cancer Research
         Internal Medicine
         Hematology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-006-0117-5/MediaObjects/432_2006_117_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-006-0117-5/MediaObjects/432_2006_117_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-006-0117-5/MediaObjects/432_2006_117_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-006-0117-5/MediaObjects/432_2006_117_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-006-0117-5/MediaObjects/432_2006_117_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-006-0117-5/MediaObjects/432_2006_117_Fig6_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-006-0117-5/MediaObjects/432_2006_117_Fig7_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-006-0117-5/MediaObjects/432_2006_117_Fig8_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-006-0117-5/MediaObjects/432_2006_117_Fig9_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-006-0117-5/MediaObjects/432_2006_117_Fig10_HTML.gif
      isPartOf:
         name:Journal of Cancer Research and Clinical Oncology
         issn:
            1432-1335
            0171-5216
         volumeNumber:132
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Yan Zhang
            affiliation:
                  name:Fudan University
                  address:
                     name:Experimental Center of Zhongshan Hospital, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mei-Yu Hu
            affiliation:
                  name:Fudan University
                  address:
                     name:Experimental Center of Zhongshan Hospital, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Wei-Zhong Wu
            affiliation:
                  name:Fudan University
                  address:
                     name:Liver Cancer Institute, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zhi-Jun Wang
            affiliation:
                  name:Fudan University
                  address:
                     name:Experimental Center of Zhongshan Hospital, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kang Zhou
            affiliation:
                  name:Fudan University
                  address:
                     name:Experimental Center of Zhongshan Hospital, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xi-Liang Zha
            affiliation:
                  name:Fudan University
                  address:
                     name:Department of Biochemistry and Molecular Biology, Shanghai Medical College, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kang-Da Liu
            affiliation:
                  name:Fudan University
                  address:
                     name:Experimental Center of Zhongshan Hospital, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Journal of Cancer Research and Clinical Oncology
      issn:
         1432-1335
         0171-5216
      volumeNumber:132
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Fudan University
      address:
         name:Experimental Center of Zhongshan Hospital, Fudan University, Shanghai, China
         type:PostalAddress
      name:Fudan University
      address:
         name:Experimental Center of Zhongshan Hospital, Fudan University, Shanghai, China
         type:PostalAddress
      name:Fudan University
      address:
         name:Liver Cancer Institute, Fudan University, Shanghai, China
         type:PostalAddress
      name:Fudan University
      address:
         name:Experimental Center of Zhongshan Hospital, Fudan University, Shanghai, China
         type:PostalAddress
      name:Fudan University
      address:
         name:Experimental Center of Zhongshan Hospital, Fudan University, Shanghai, China
         type:PostalAddress
      name:Fudan University
      address:
         name:Department of Biochemistry and Molecular Biology, Shanghai Medical College, Fudan University, Shanghai, China
         type:PostalAddress
      name:Fudan University
      address:
         name:Experimental Center of Zhongshan Hospital, Fudan University, Shanghai, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Yan Zhang
      affiliation:
            name:Fudan University
            address:
               name:Experimental Center of Zhongshan Hospital, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Mei-Yu Hu
      affiliation:
            name:Fudan University
            address:
               name:Experimental Center of Zhongshan Hospital, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Wei-Zhong Wu
      affiliation:
            name:Fudan University
            address:
               name:Liver Cancer Institute, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Zhi-Jun Wang
      affiliation:
            name:Fudan University
            address:
               name:Experimental Center of Zhongshan Hospital, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Kang Zhou
      affiliation:
            name:Fudan University
            address:
               name:Experimental Center of Zhongshan Hospital, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Xi-Liang Zha
      affiliation:
            name:Fudan University
            address:
               name:Department of Biochemistry and Molecular Biology, Shanghai Medical College, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Kang-Da Liu
      affiliation:
            name:Fudan University
            address:
               name:Experimental Center of Zhongshan Hospital, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Experimental Center of Zhongshan Hospital, Fudan University, Shanghai, China
      name:Experimental Center of Zhongshan Hospital, Fudan University, Shanghai, China
      name:Liver Cancer Institute, Fudan University, Shanghai, China
      name:Experimental Center of Zhongshan Hospital, Fudan University, Shanghai, China
      name:Experimental Center of Zhongshan Hospital, Fudan University, Shanghai, China
      name:Department of Biochemistry and Molecular Biology, Shanghai Medical College, Fudan University, Shanghai, China
      name:Experimental Center of Zhongshan Hospital, Fudan University, Shanghai, China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(100)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

5.27s.

LINK . SPRINGER . COM {}